These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6140654)

  • 21. THE EFFECTS OF ENDOCRINE GLAND ABLATION AND OF CORTICOSTEROID SUBSTITUTION ON THE RATE OF WATER TURNOVER IN THE ADRENALECTOMIZED RAT.
    FOY JM; SCHNIEDEN H
    J Endocrinol; 1965 Jan; 31():89-94. PubMed ID: 14241739
    [No Abstract]   [Full Text] [Related]  

  • 22. [Medical management of malignant gliomas].
    Béhin A; Delattre JY
    Cancer Radiother; 2000 Nov; 4 Suppl 1():67s-83s. PubMed ID: 11194966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CLINICAL STUDIES UTILIZING A NEW METHOD FOR THE SERIAL DETERMINATION OF PLASMA CORTICOIDS.
    MURPHY BE; HOOD AB; PATTEE CJ
    Can Med Assoc J; 1964 Mar; 90(13):775-80. PubMed ID: 14132169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of early corticosteroid therapy for Landau-Kleffner syndrome.
    Lerman P; Lerman-Sagie T; Kivity S
    Dev Med Child Neurol; 1991 Mar; 33(3):257-60. PubMed ID: 1709123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Analytical and analogical study of a model of the adrenal-postpituitary function (author's transl)].
    Bernard-Weil E; Duvelleroy M; Mulletin J
    Ann Endocrinol (Paris); 1976; 37(1):1-17. PubMed ID: 1015788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Exploration of antepituitary corticotropic function by determination of plasma corticoids during the infusion of postpituitary extract].
    RAPPAPORT R; SEBAOUN J; MODAI J; DRAY F; GILBERT-DREYFUS
    Ann Endocrinol (Paris); 1963; 24():445-50. PubMed ID: 13973126
    [No Abstract]   [Full Text] [Related]  

  • 27. HYPOPHYSO-ADRENAL REGULATION OF MOULTING IN THE TOAD.
    STEFANO FJ; DONOSO AO
    Gen Comp Endocrinol; 1964 Oct; 4():473-80. PubMed ID: 14216254
    [No Abstract]   [Full Text] [Related]  

  • 28. Phase II studies of dianhydrogalactitol-based combination chemotherapy for recurrent brain tumors.
    Eagan RT; Creagan ET; Bisel HF; Layton DD; Groover RV; Herman RC
    Oncology; 1981; 38(1):4-6. PubMed ID: 7443176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemodynamic response to vasopressin in dehydrated human subjects.
    Huch KM; Wall BM; Mangold TA; Bobal MA; Cooke CR
    J Investig Med; 1998 Aug; 46(6):312-8. PubMed ID: 9737094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination carmustine (BCNU) and dianhydrogalactitol in the treatment of primary brain tumors recurring after irradiation.
    Eagan RT; Dinapoli RP; Hermann RC; Groover RV; Layton DD; Scott M
    Cancer Treat Rep; 1982 Aug; 66(8):1647-9. PubMed ID: 7105055
    [No Abstract]   [Full Text] [Related]  

  • 31. [The ACTH-oxytocin association in the treatment of edematigenous cerebral diseases].
    Ferrari E; Ragonese G
    Acta Neurol (Napoli); 1970; 25(4):435-40. PubMed ID: 4319047
    [No Abstract]   [Full Text] [Related]  

  • 32. Responses induced by arginine-vasopressin injection in the plasma concentrations of adrenocorticotropic hormone, cortisol, growth hormone and metabolites around weaning time in goats.
    Katoh K; Yoshida M; Kobayashi Y; Onodera M; Kogusa K; Obara Y
    J Endocrinol; 2005 Nov; 187(2):249-56. PubMed ID: 16293772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of the hypophyseo-adrenal cortical system on the vasopressinergic system].
    Filaretova LP; Podvigina TT; Balashov IuG; Filaretov AA
    Fiziol Zh SSSR Im I M Sechenova; 1989 Jul; 75(7):980-5. PubMed ID: 2553502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Evolution of chemotherapy for malignant brain tumors].
    Takeshima H; Kuratsu J
    No Shinkei Geka; 2003 Jul; 31(7):725-34. PubMed ID: 12884787
    [No Abstract]   [Full Text] [Related]  

  • 35. Urinary steroids in adrenocortical tumor; excretion of corticoids and 17-ketosteroids on admission, after ACTH, following resection, after withdrawal of ACTH, and upon recurrence of masculinizing carcinoma.
    HARDY JD
    Ann Surg; 1953 Nov; 138(5):765-8. PubMed ID: 13092810
    [No Abstract]   [Full Text] [Related]  

  • 36. [Indications for ACTH and corticoids in childhood encephalopathies].
    VIALATTE J; SATGE P; PIGOT PY
    Sem Hop Ther Paris; 1962 Nov; 38():814-5. PubMed ID: 13997013
    [No Abstract]   [Full Text] [Related]  

  • 37. Hypopituitarism.
    Higham CE; Johannsson G; Shalet SM
    Lancet; 2016 Nov; 388(10058):2403-2415. PubMed ID: 27041067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on the mechanism of vasopressin-induced steroid secretion in man.
    Gwinup G
    Metabolism; 1965 Dec; 14(12):1282-6. PubMed ID: 4284817
    [No Abstract]   [Full Text] [Related]  

  • 39. Paclitaxel for the treatment of progressive or recurrent childhood brain tumors: a pediatric oncology phase II study.
    Hurwitz CA; Strauss LC; Kepner J; Kretschmar C; Harris MB; Friedman H; Kun L; Kadota R
    J Pediatr Hematol Oncol; 2001; 23(5):277-81. PubMed ID: 11464982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vasopressin in the diagnostic evaluation of pituitary and hypothalamic function.
    Toft H; Buus O; Nielsen E
    Acta Endocrinol (Copenh); 1971 Jun; 67(2):393-400. PubMed ID: 4325332
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.